Associated Papers
The NPC1L1 Gene Exerts a Notable Impact on the Reduction of Low-Density Lipoprotein Cholesterol in Response to Hyzetimibe: A Factorial-Designed Clinical Trial.
Liao J et al.
Frontiers in Pharmacology, 2022
Characterization of the NPC1L1 gene and proteome from an exceptional responder to ezetimibe.
Schweitzer M et al.
Atherosclerosis, 2016
Select a paper to view details